icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
S-collate cohort 'real-life' study: efficacy and safety of peginterferon alfa-2a (40KD) in 1233 patients with chronic hepatitis B according to Asian and Caucasian race
 
 
  Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
 
Patrick Marcellin, Qing Xie, Teerha Piratvisuth, Graham R Foster, Robert Flisiak, XinYue Chen, Yao Xie, Yongping Chen, Seung Woon Paik, Diethelm Messinger, Loredana Regep, Heiner Wedemeyer
Service d'Hepatologie and INSERM CRB3/U773, University Paris-Diderot, Clichy, France

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif